Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma

بواسطة Mantopoulos, Dimosthenis, Kendra, Kari L., Letson, Alan D., Cebulla, Colleen M.
الحاوية / القاعدة JAMA Ophthalmol (2015)

Refractory dermatitis contributed by pityriasis versicolor: a case report

بواسطة Li, Mingjia, Spaccarelli, Natalie, Kendra, Kari, Wu, Richard C., Verschraegen, Claire
الحاوية / القاعدة J Med Case Rep (2021)

Co-Treatment of Hairy Cell Leukemia and Melanoma with the BRAF Inhibitor Dabrafenib

بواسطة Blachly, James S., Lozanski, Gerard, Lucas, David M., Grever, Michael R., Kendra, Kari, Andritsos, Leslie A.
الحاوية / القاعدة J Natl Compr Canc Netw (2015)

Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to Interferon-Alpha

بواسطة Zimmerer, Jason M., Lesinski, Gregory B., Ruppert, Amy S., Radmacher, Michael D., Noble, Carl, Kendra, Kari, Walker, Michael J., Carson, William E.
منشور في 2008

A Pilot Study of Bevacizumab and Interferon-α2b in Ocular Melanoma

بواسطة Guenterberg, Kristan D., Grignol, Valerie P., Relekar, Kiran V., Varker, Kimberly A., Chen, Helen X., Kendra, Kari L., Olencki, Thomas E., Carson, William E.
الحاوية / القاعدة Am J Clin Oncol (2011)

Hybrid Capture‐Based Genomic Profiling Identifies BRAF V600 and Non‐V600 Alterations in Melanoma Samples Negative by Prior Testing

بواسطة Boussemart, Lise, Nelson, Annie, Wong, Michael, Ross, Jeffrey S., Sosman, Jeffrey, Mehnert, Janice, Daniels, Gregory, Kendra, Kari, Ali, Siraj Mahamed, Miller, Vincent A., Schrock, Alexa B.
الحاوية / القاعدة Oncologist (2019)

Impact of age-related T cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: a prospective cohort study

بواسطة Galloway, Jason E., Holderbaum, Andrea M., Arya, Namrata, Zhang, Suohui, Bodnar, Michael S., Norman, Ruthann, Carson, William E., Yu, Lianbo, Kendra, Kari L., Burd, Christin E.
الحاوية / القاعدة Aging Cancer (2020)

A Phase II trial of Bevacizumab and High Dose Interferon Alpha-2B in Metastatic Melanoma

بواسطة Grignol, Valerie P., Olencki, Thomas, Relekar, Kiran, Taylor, Cynthia, Kibler, Amanda, Kefauver, Cheryl, Wei, Lai, Walker, Michael J., Chen, Helen X., Kendra, Kari, Carson, William E.
منشور في 2011

Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib

بواسطة Liebner, David A., Walston, Steven A., Cavaliere, Robert, Powers, Ciaran J., Sauvageau, Eric, Lehman, Norman L., Slone, Hasel Wayne, Xu-Welliver, Meng, Xia, Fen, Kendra, Kari L.
الحاوية / القاعدة Melanoma Res (2014)

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

بواسطة Monk, Paul, Lam, Elaine, Mortazavi, Amir, Kendra, Kari, Lesinski, Gregory B., Mace, Thomas A., Geyer, Susan, Carson, William E., Tahiri, Sanaa, Bhinder, Arvinder, Clinton, Steven K., Olencki, Thomas
منشور في 2014

Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells

بواسطة Yang, Jennifer, Bill, Matthew A., Young, Gregory S., La Perle, Krista, Landesman, Yosef, Shacham, Sharon, Kauffman, Michael, Senapedis, William, Kashyap, Trinayan, Saint-Martin, Jean-Richard, Kendra, Kari, Lesinski, Gregory B.
منشور في 2014

The exportin-1 inhibitor selinexor exerts superior anti-tumor activity when combined with T cell checkpoint inhibitors

بواسطة Farren, Matthew R., Hennessey, Rebecca C., Shakya, Reena, Elnaggar, Omar, Young, Gregory, Kendra, Kari, Landesman, Yosef, Elloul, Sivan, Crochiere, Marsha, Klebanov, Boris, Kashyap, Trinayan, Burd, Christin E., Lesinski, Gregory B.
الحاوية / القاعدة Mol Cancer Ther (2017)

Development and Validation of Sensitive Liquid Chromatography/Tandem Mass Spectrometry Methods for Quantification of Bendamustine in Mouse Brain Tissue

بواسطة He, Lei, Grecula, John C., Ling, Yonghua, Enzerra, Michael D., Ammirati, Mario, Kendra, Kari, Cavaliere, Robert, Mayr, Nina, McGregor, John, Olencki, Thomas, Mrozek, Ewa, Matharbootham, Mani, Oluigbo, Chima, Phelps, Mitch A.
منشور في 2012

A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma

بواسطة Hasanov, Merve, Rioth, Matthew J., Kendra, Kari, Hernandez-Aya, Leonel, Joseph, Richard W., Williamson, Stephen, Chandra, Sunandana, Shirai, Keisuke, Turner, Christopher D., Lewis, Karl, Crowley, Elizabeth, Moscow, Jeffrey, Carter, Brett, Patel, Sapna
الحاوية / القاعدة Cancers (Basel) (2020)

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

بواسطة Li, Mingjia, Spakowicz, Daniel, Burkart, Jarred, Patel, Sandip, Husain, Marium, He, Kai, Bertino, Erin M., Shields, Peter G., Carbone, David P., Verschraegen, Claire F., Presley, Carolyn J., Otterson, Gregory A., Kendra, Kari, Owen, Dwight H.
الحاوية / القاعدة J Cancer Res Clin Oncol (2019)

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients

بواسطة King, David M., Albertini, Mark R., Schalch, Heidi, Hank, Jacquelyn A., Gan, Jacek, Surfus, Jean, Mahvi, David, Schiller, Joan H., Warner, Thomas, Kim, KyungMann, Eickhoff, Jens, Kendra, Kari, Reisfeld, Ralph, Gillies, Stephen D., Sondel, Paul
منشور في 2004

A Phase I trial of Bortezomib and Interferon Alfa-2B in Metastatic Melanoma

بواسطة Markowitz, Joseph, Luedke, Eric A., Grignol, Valerie P., Hade, Erinn M., Paul, Bonnie K., Mundy-Bosse, Bethany L., Brooks, Taylor R., Dao, Thao-Vi, Kondalasula, Sri Vidya, Lesinski, Gregory B., Olencki, Thomas, Kendra, Kari L., Carson, William E.
منشور في 2014

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

بواسطة Suarez-Kelly, Lorena P., Levine, Kala M., Olencki, Thomas E., del Campo, Sara E. Martin, Streacker, Elizabeth A., Brooks, Taylor R., Karpa, Volodymyr I., Markowitz, Joseph, Bingman, Anissa K., Geyer, Susan M., Kendra, Kari L., Carson, William E.
الحاوية / القاعدة Cancer Immunol Immunother (2019)

Phase II Trial of Intravenous Administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma

بواسطة Galanis, Evanthia, Markovic, Svetomir N, Suman, Vera J, Nuovo, Gerard J, Vile, Richard G, Kottke, Timothy J, Nevala, Wendy K, Thompson, Michael A, Lewis, Jean E, Rumilla, Kandelaria M, Roulstone, Victoria, Harrington, Kevin, Linette, Gerald P, Maples, William J, Coffey, Matt, Zwiebel, James, Kendra, Kari
منشور في 2012

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

بواسطة Abu-Sbeih, Hamzah, Ali, Faisal S., Naqash, Abdul Rafeh, Owen, Dwight H., Patel, Sandipkumar, Otterson, Gregory A., Kendra, Kari, Ricciuti, Biagio, Chiari, Rita, De Giglio, Andrea, Sleiman, Joseph, Funchain, Pauline, Wills, Beatriz, Zhang, Jiajia, Naidoo, Jarushka, Philpott, Jessica, Gao, Jianjun, Subudhi, Sumit K., Wang, Yinghong
الحاوية / القاعدة J Clin Oncol (2019)